stock & financial message boards
  Joined Today: 14

  Login  |  Registration |  Site Map  |  Stock Market Blogs reaching thousands of users every day  |  Recent Activity  |    |

TEVA Teva Pharmaceutical Industries Ltd, Stock Message Board

All Messages

TEVA Message Board Home | Join The TEVA Group | 

Page [1 of 7] < Prev
|1|2|3|4|5|6|7
|Next >
#102: COPAXONE(R) Demonstrated Protective Effect in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
TheMachine
September 20, 2008 01:18:32 AM
PreCISe Data Presented at World Congress on Treatment and Research in Multiple Sclerosis New data from PreCISe, in clinically isolated syndrome patients, have ...
view message
ignore post
recommend post
#101: Teva Completes Acquisition of Bentley Pharmaceuticals
TheMachine
July 27, 2008 07:19:07 AM
-Teva Gains a Strong Platform to Become a Leading Player in Spain- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has completed its...
view message
ignore post
recommend post
#100: TEVA News Teva Provides Update on Generic Celebrex(R) Litigation
NewsBot
March 21, 2007 07:15:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its...
view message
ignore post
recommend post
#99: TEVA News Teva Receives First U.S. Approval for Generic Uniretic(R) Tablets
NewsBot
March 9, 2007 06:50:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company’s...
view message
ignore post
recommend post
#98: TEVA News Teva Receives Approval for Generic Dostinex(R) Tablets
NewsBot
March 8, 2007 08:18:00 AM
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the...
view message
ignore post
recommend post
#97: TEVA News Teva Announces the Office of the Chief Executive Officer
NewsBot
March 7, 2007 09:36:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced the Office of the Chief Executive Officer, which will now include George Barrett,...
view message
ignore post
recommend post
#96: TEVA News Teva to Sell Oxycodone Through the End of 2007
NewsBot
March 6, 2007 05:25:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it will continue to sell its generic version of OxyContin® tablets at least...
view message
ignore post
recommend post
#95: TEVA News Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
NewsBot
March 5, 2007 05:18:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has reached an agreement with Biovail Corporation regarding Bupropion...
view message
ignore post
recommend post
#94: TEVA News Teva Announces Approval of Alprazolam ER Tablets
NewsBot
March 1, 2007 08:22:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's...
view message
ignore post
recommend post
#93: TEVA News Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
NewsBot
February 22, 2007 06:48:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the...
view message
ignore post
recommend post
#92: TEVA News Teva Reports Fourth Quarter and Full Year 2006 Results
NewsBot
February 12, 2007 10:05:00 PM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter and the full year ended December 31, 2006. Net sales for the...
view message
ignore post
recommend post
#91: TEVA News Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 300 mg Under Agreement with Anchen and IMPAX
NewsBot
December 18, 2006 05:00:00 AM
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has commercially shipped Bupropion Hydrochloride Extended-Release ...
view message
ignore post
recommend post
#90: TEVA News Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
NewsBot
November 29, 2006 12:28:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the...
view message
ignore post
recommend post
#89: TEVA News Teva Announces Approval of Ondansetron Injection USP
NewsBot
November 22, 2006 10:42:00 AM
JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the ...
view message
ignore post
recommend post
#88: TEVA News Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
NewsBot
November 21, 2006 05:48:00 AM
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has reached a comprehensive agreement with Pfizer Inc (NYSE: PFE) regarding...
view message
ignore post
recommend post
Page [1 of 7] < Prev
|1|2|3|4|5|6|7
|Next >

Group Home | Login if you want to post a message